Molokanova and her team invented novel nanotherapeutics that exclusively target pathologically activated receptors in the brain, and thus provide safe and efficient treatment for many neurological disorders. Molokanova produced multiple cutting-edge inventions, including super-fast quantum dot-based sensors of electrical processes in cells, a graphene-mediated optical stimulation platform for functional activation of cells (alternative to optogenetics), and multimodal graphene-based sensors for monitoring the functional activity of cells.įor NeurANO, Dr. Taking advantage of her highly interdisciplinary vision, Dr. ParkinSense is an application designed to track and mitigate symptoms related to Parkinsons Disease. Molokanova’s research is encompassing such dispart areas as biophysics of ion channels (UC Berkeley), clinical neurology in Parkinson’s patients and astronauts from the space station Mir (Institute of Space Neurology, Austria), neuroscience drug discovery (Amgen), neurodegenerative disorders (SBP Medical Research Institute), and high content imaging (Invitrogen). Molokanova acquired vast practical expertise in biophysics, neuroscience, biophotonics, electrophysiology, mathematical modeling, and advanced optical methods. in Biological Sciences from the Bogomoletz Institute of Physiology (Kiev, Ukraine). A team of researchers have created an artificial enzyme that could help form a new treatment for the neurodegenerative Parkinson’s disease. Elena Molokanova is the Founder of NeurANO Bioscience, a neuroscience drug discovery start-up with a mission to resolve a long-standing neuroscience problem and develop novel nanotherapeutics targeting glutamatergic pathways in the brain.Īfter receiving M.S.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |